NO902099L - Analogifremgangsmaate for fremstilling av terapeutisk aktive arylsulfonamider. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive arylsulfonamider.Info
- Publication number
- NO902099L NO902099L NO90902099A NO902099A NO902099L NO 902099 L NO902099 L NO 902099L NO 90902099 A NO90902099 A NO 90902099A NO 902099 A NO902099 A NO 902099A NO 902099 L NO902099 L NO 902099L
- Authority
- NO
- Norway
- Prior art keywords
- arylsulphonamides
- thromboxane
- preparation
- therapeutic active
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3915506A DE3915506A1 (de) | 1989-05-12 | 1989-05-12 | Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE3932403A DE3932403A1 (de) | 1989-05-12 | 1989-09-28 | Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (4)
Publication Number | Publication Date |
---|---|
NO902099D0 NO902099D0 (no) | 1990-05-11 |
NO902099L true NO902099L (no) | 1990-11-13 |
NO176176B NO176176B (no) | 1994-11-07 |
NO176176C NO176176C (no) | 1995-02-15 |
Family
ID=25880794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO902099A NO176176C (no) | 1989-05-12 | 1990-05-11 | Analogifremgangsmåte for fremstilling av terapeutisk aktive arylsulfonamider |
Country Status (21)
Country | Link |
---|---|
US (3) | US5294626A (no) |
EP (1) | EP0397044B1 (no) |
JP (1) | JP2868283B2 (no) |
KR (1) | KR0153527B1 (no) |
AT (1) | ATE132138T1 (no) |
AU (1) | AU627024B2 (no) |
CA (1) | CA2016646C (no) |
DE (2) | DE3932403A1 (no) |
DK (1) | DK0397044T3 (no) |
ES (1) | ES2083394T3 (no) |
FI (1) | FI95372C (no) |
GR (1) | GR3019044T3 (no) |
HU (1) | HU214586B (no) |
IE (1) | IE74207B1 (no) |
IL (1) | IL94347A0 (no) |
MX (1) | MX9202816A (no) |
NO (1) | NO176176C (no) |
NZ (1) | NZ233638A (no) |
PT (1) | PT93994B (no) |
RU (1) | RU2096405C1 (no) |
UA (1) | UA26136C2 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153214A (en) * | 1989-06-28 | 1992-10-06 | Ciba-Geigy Corporation | Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity |
DE4025818A1 (de) * | 1990-08-16 | 1992-02-20 | Bayer Ag | Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate |
US5286736A (en) * | 1990-11-22 | 1994-02-15 | Dr. Karl Thomae Gmbh | Pyridyl compounds and pharmaceutical compositions containing these compounds |
DE4037112A1 (de) * | 1990-11-22 | 1992-05-27 | Thomae Gmbh Dr K | Neue pyridylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5374641A (en) * | 1991-02-25 | 1994-12-20 | Terumo Kabushiki Kaisha | N-(3-pyridylalkyl)sulfonamide compounds which have useful pharmaceutical activity |
GB9107043D0 (en) * | 1991-04-04 | 1991-05-22 | Pfizer Ltd | Therapeutic agents |
DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
FR2686339B1 (fr) * | 1992-01-22 | 1994-03-11 | Adir Cie | Nouveaux amides et sulfonamides naphtaleniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
DE4213919A1 (de) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
CA2347939C (en) | 1998-10-23 | 2006-10-10 | Akira Matsumori | Composition for the treatment of rheumatism, hepatitis or pancreatitis |
US8633237B2 (en) | 2009-04-09 | 2014-01-21 | Merck Sharp & Dohme B.V. | Indane derivatives |
KR101701943B1 (ko) | 2009-11-13 | 2017-02-02 | 도레이 카부시키가이샤 | 당뇨병의 치료 또는 예방약 |
US9955802B2 (en) | 2015-04-08 | 2018-05-01 | Fasteners For Retail, Inc. | Divider with selectively securable track assembly |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1134828A (en) * | 1978-12-28 | 1982-11-02 | Tadao Tanouchi | Pyridine derivatives |
EP0098690B1 (en) * | 1982-06-14 | 1987-09-09 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
US4518602A (en) * | 1982-10-07 | 1985-05-21 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase |
US4563446A (en) * | 1983-07-27 | 1986-01-07 | Takeda Chemical Industries, Ltd. | Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines |
DE3689506D1 (de) * | 1985-10-09 | 1994-02-17 | Shell Int Research | Neue Acrylsäureamide. |
DE3623944A1 (de) * | 1986-07-16 | 1988-02-11 | Thomae Gmbh Dr K | Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
GB8708233D0 (en) * | 1987-04-07 | 1987-05-13 | Smith Kline French Lab | Pharmaceutically active compounds |
WO1989001330A2 (en) * | 1987-08-20 | 1989-02-23 | Smith Kline & French Laboratories Limited | W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases |
-
1989
- 1989-09-28 DE DE3932403A patent/DE3932403A1/de not_active Withdrawn
-
1990
- 1990-05-04 AT AT90108433T patent/ATE132138T1/de not_active IP Right Cessation
- 1990-05-04 ES ES90108433T patent/ES2083394T3/es not_active Expired - Lifetime
- 1990-05-04 DK DK90108433.5T patent/DK0397044T3/da active
- 1990-05-04 DE DE59009994T patent/DE59009994D1/de not_active Expired - Fee Related
- 1990-05-04 EP EP90108433A patent/EP0397044B1/de not_active Expired - Lifetime
- 1990-05-10 KR KR1019900006587A patent/KR0153527B1/ko not_active IP Right Cessation
- 1990-05-10 PT PT93994A patent/PT93994B/pt not_active IP Right Cessation
- 1990-05-10 IL IL94347A patent/IL94347A0/xx not_active IP Right Cessation
- 1990-05-10 NZ NZ233638A patent/NZ233638A/en unknown
- 1990-05-11 FI FI902358A patent/FI95372C/fi not_active IP Right Cessation
- 1990-05-11 AU AU54924/90A patent/AU627024B2/en not_active Ceased
- 1990-05-11 HU HU903013A patent/HU214586B/hu not_active IP Right Cessation
- 1990-05-11 JP JP2122825A patent/JP2868283B2/ja not_active Expired - Lifetime
- 1990-05-11 NO NO902099A patent/NO176176C/no not_active IP Right Cessation
- 1990-05-11 CA CA002016646A patent/CA2016646C/en not_active Expired - Fee Related
- 1990-05-11 IE IE170890A patent/IE74207B1/en not_active IP Right Cessation
- 1990-05-14 US US07/523,167 patent/US5294626A/en not_active Expired - Fee Related
-
1992
- 1992-01-08 RU SU925010477A patent/RU2096405C1/ru active
- 1992-06-12 MX MX9202816A patent/MX9202816A/es unknown
-
1993
- 1993-05-12 UA UA93002789A patent/UA26136C2/uk unknown
- 1993-11-18 US US08/154,647 patent/US5426119A/en not_active Expired - Fee Related
-
1995
- 1995-03-21 US US08/407,180 patent/US5681961A/en not_active Expired - Fee Related
-
1996
- 1996-02-21 GR GR960400447T patent/GR3019044T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO902099L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylsulfonamider. | |
PT719253E (pt) | Piperidinas 3-amino-5-carboxi-substituidas e pirrolidinas 3-amino-4-carboxi-substituidas como antagonistas de taquicinina | |
ATE301117T1 (de) | Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
DE69131359D1 (de) | Kondensierte Thiazolverbindungen, ihre Darstellung und ihre Anwendung | |
EA200000996A1 (ru) | Конденсированные с арилом азаполициклические соединения | |
NO914567D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridylderivate | |
DE60234024D1 (de) | Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält | |
ATE100102T1 (de) | Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
DK0815109T3 (da) | Fremgangsmåde til fremstilling af estere af anhydroecgonin | |
RU93045455A (ru) | Производные пиперидина, способ их получения и фармацевтическая композиция на их основе |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2000 |